Who owns the RESOLIAN BIOANALYTICS trademark?

The RESOLIAN BIOANALYTICS trademark is owned by Alliance Pharma Inc..

What class is the RESOLIAN BIOANALYTICS trademark registered in?

The RESOLIAN BIOANALYTICS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for RESOLIAN BIOANALYTICS?

The USPTO serial number for RESOLIAN BIOANALYTICS is 97796233.

What is the registration number for RESOLIAN BIOANALYTICS?

RESOLIAN BIOANALYTICS is registered under USPTO registration number 7410178.

RES

USPTO Trademark Record

REGISTERED

RESOLIAN BIOANALYTICS

SN 97796233·Reg 7410178·Filed Feb 15, 2023

Owner Alliance Pharma Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

RESOLIAN BIOANALYTICS (Serial No. 97796233), Registration No. 7410178, is a registered US trademark filed on Feb 15, 2023 by Alliance Pharma Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: June 04, 2030

Mark Intelligence

RESOLIAN BIOANALYTICS (Reg. #7410178) is a registered US trademark that has been protecting its owner, Alliance Pharma Inc., since 2023. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 15, 2023

SERIAL

97796233

REG#

7410178

REGISTERED

Jun 04, 2024

Owner

Applicant

Alliance Pharma Inc.

Entity

Corporation

State

Address

Great Valley Corporate Center, 17 Lee Boulevard, Malvern, PA, 19355

Country

Attorney

NameChristopher D. Olszyk, Jr.

Law firm

Christopher D. Olszyk, Jr. FOX ROTHSCHILD LLP

Docket

032735.00052

Address

997 LENOX DRIVE, BLDG. 3, LAWRENCEVILLE, NJ 08648-2311, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateFeb 15, 2023

Serial Number97796233

Registration No.7410178

Registration DateJun 04, 2024

Status DateJun 04, 2024

Published for OppositionJan 09, 2024

Mark TypeStandard characters

Attorney Docket032735.00052

Status DescriptionLive and registered

Filing Signals

FILED

2023

YEARS AGO

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: May 17, 2023

First use in commerce: May 17, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

22 events

REGISTERED-PRINCIPAL REGISTER

Jun 04, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jun 04, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Apr 30, 2024

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Apr 30, 2024

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 19, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Apr 19, 2024

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Apr 01, 2024

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Apr 01, 2024

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 05, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jan 09, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 09, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 20, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 02, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 29, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 28, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 28, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

ASSIGNED TO EXAMINER

Nov 14, 2023

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Nov 14, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Nov 14, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 14, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 06, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 18, 2023

NEW APPLICATION ENTERED

RESOLIAN BIOANALYTICS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Alliance Pharma Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Christopher D. Olszyk, Jr.

Resources

Company